Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox
Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

NCT00538629

CompletedN/A

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions: Bipolar Disorder, Schizophrenia

Interventions: no intervention, no intervention

Investigation of the impact of Zeldox on metabolic parametres in patients with bipolar disorder or with schizophrenia and impact of the treatment for the quality of life

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

Manic and mixed episodes of up to moderate severity in patients with type I and II bipolar disorder and schizophrenia; either first diagnosed or repeated episodes.

Exclusion Criteria:

Patients with a history of hypersenzitivity to Ziprasidone. Previous insufficiency of the Ziprasidone´s treatment. The break of the previous therapeutic condition.